October 26, 2017
Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update
Third quarter 2017 net revenues of $50.1 million, reflecting 131 percent growth versus third quarter 2016 and 31 percent growth versus second quarter 2017 1,683 active patients at September 30, 2017, an increase of 71 percent from September 30, 2016, and 15 percent… Read More
learn more
October 16, 2017
Novocure Announces Data Presentations at the IASLC 18th World Conference on Lung Cancer
The conference is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today five data presentations at the International Associations for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer, October 15 to… Read More
learn more
October 2, 2017
Novocure to Report Third Quarter 2017 Financial Results
ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2017 on Thursday, October 26, 2017, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss its financial results for the three and… Read More
learn more
